Access to AI in Medical Education: Innovating and Inclusive

By Sumona Bose

December 15, 2023

Introduction

Artificial intelligence (AI) has become an innovative force in various industries, and its potential in healthcare is no exception. Access to AI in Medical Education is an important area of exploration. In the field of medical education, AI is being explored for its applications in training, learning, simulation, curriculum development, and assessment tools. This article aims to highlight the inclusive nature of AI in medical education, showcasing its potential to transfigure the way we teach and learn.

Expanding Possibilities

AI has the ability to enhance medical education in numerous ways. For instance, machine-learning bots can now generate content such as Wikipedia articles, assignments, novels, and book chapters. This raises questions about the suitability of current policies and regulations, copyright concerns, and the need for alternative assessment methods to adapt to these advancements.

Defining AI in Medical Education

Artificial Intelligence (AI) is the science and engineering of creating intelligent machines and smart computer programs. It encompasses a wide range of applications, from general research on learning and perception to specialized tasks like diagnosing diseases and driving cars. In the context of medical education, AI can be utilized to improve various specialties, including medical imaging, cancer histopathology, cardiology, and pediatric ophthalmology.

Exploring AI in Medical Education

The applications of AI in medical education are vast and promising. For example, AI can be used in surgical education and training, reshaping the teaching of radiology, improving AI literacy in oral and dental education, and assessing surgical expertise. The future physician will need to effectively incorporate AI in patient care tasks, collaborate with patients using AI for self-management, and utilize AI to improve healthcare operations and reduce errors.

Addressing Key Questions

The integration of AI in medical education raises important questions that need to be addressed. How will AI-driven changes impact undergraduate and postgraduate medical curricula? How can AI be used to empower disadvantaged groups, including ethnic and religious minorities? How can AI preserve the capacity of physicians to focus on tasks that require human expertise while improving accessibility to healthcare for vulnerable populations? What role should policymakers, tech companies, research institutes, and society play in adapting medical education to the introduction of AI? Additionally, what alternative assessment methods can replace traditional question formats?

Conclusion

AI has the potential to reshape medical education by providing innovative and inclusive solutions. By embracing AI in medical curricula, teaching and learning methods, and student assessment, we can prepare future physicians to effectively utilize AI in patient care.

 

Reference url

Recent Posts

Cemiplimab Cervical Cancer Access
Cemiplimab Cervical Cancer Access Navigating Treatment and Value

By João L. Carapinha

June 24, 2026

Cemiplimab Cervical Cancer Access has been endorsed by NICE for adults with recurrent or metastatic cervical cancer that has progressed after platinum-based chemotherapy, provided patients have not previously received immunotherapy. The final draft guidance confirms that this PD-1 inhibitor deliv...
pharmaceutical innovation ROI
Shifting Perspectives on Pharmaceutical Innovation ROI as Socioeconomic Investment

By João L. Carapinha

June 24, 2026

Pharmaceutical innovation ROI is shifting from a narrow budget metric to a powerful indicator of societal return. Between 2014 and 2024, a 3.1-year rise in utilization-weighted mean drug vintage across 29 European countries prevented 1.83 million years of life lost before age 85 and saved 20.9 mi...
CAR T-Cell Therapy
Pioneering CAR T-Cell Therapy for Advanced Gastric Cancer

By João L. Carapinha

June 24, 2026

CAR T-Cell Therapy has reached a historic milestone with the approval of satri-cel, the world’s first authorized CAR T treatment for any solid tumor. The therapy targets Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma that has progressed after at l...